Toxo-Mox – Broad Spectrum Antibiotic for Companion Animals

Description

Toxo-Mox – Broad Spectrum Antibiotic for Companion Animals

Full Description: Toxo-Mox is a broad-spectrum antibiotic containing Amoxycillin in combination with Clavulanic acid, providing effective treatment against β-lactamase-resistant infections. It is indicated for various bacterial infections in dogs and cats, including urinary tract infections (UTIs), skin and soft tissue infections, and systemic bacteremia. In cats, it is also effective for upper respiratory tract infections like pneumonia. Toxo-Mox DS is ideal for administration to young animals due to its gentle formula. The product is available in tablet, oral suspension, and injectable forms, offering versatile use for a range of treatment scenarios.

Features:

• Effective Against β-Lactamase-Resistant Infections: Combines Amoxycillin with Clavulanic acid to combat a wide range of bacterial infections.
• Broad Spectrum: Useful for UTIs, skin and soft tissue infections, respiratory infections, and systemic bacteremia in dogs and cats.
• Variety of Forms: Available as tablets, oral suspension, and injection, allowing for flexible administration.

Indications: Toxo-Mox is recommended for:

• Urinary Tract Infections (UTIs): Effective in treating bacterial UTIs in dogs.
• Skin and Soft Tissue Infections: Indicated for managing skin infections and soft tissue issues in dogs and cats.
• Systemic Bacteremia: Useful for treating systemic bacterial infections.
• Upper Respiratory Tract Infections: Effective for pneumonia and other respiratory conditions in cats.
• Periodontal Infections: Can be used for treating dental infections.

Composition: Toxo-Mox contains a combination of Amoxycillin and Clavulanic acid:

• Tablets: Available in 200 mg Amoxycillin + 50 mg Clavulanic Acid and 400 mg Amoxycillin + 100 mg Clavulanic Acid.
• Oral Suspension: 200 mg Amoxycillin + 28.5 mg Clavulanic Acid.
• Injection: Available in 500 mg Amoxycillin + 100 mg Clavulanic Acid and 250 mg Amoxycillin + 50 mg Clavulanic Acid.

Role of Key Ingredients:

• Amoxycillin: An antibiotic effective against a wide range of bacteria.
• Clavulanic Acid: A β-lactamase inhibitor that enhances the effectiveness of Amoxycillin by preventing bacterial resistance.

Dosage: The dosage for Toxo-Mox varies based on the form:

• Tablets: 12.5 mg/kg body weight twice daily.
• Oral Suspension: 12.5 mg/kg twice daily.
• Injection: 8.75 mg/kg via IM every 24 hours or IV every 8 hours.
• Skin and Soft Tissue Infections: 1 ml/3 kg body weight twice daily.
• Periodontal Infections: 1 ml/3 kg body weight for 5-7 days.
• Deep Pyoderma: 1 ml/3 kg body weight for 21-30 days.

Presentation: Toxo-Mox is available in different pack sizes and forms:

• Tablets: 250/500 mg strips.(10 TAB STRIP)
• Oral Suspension: 228.5 mg/5 ml ( 30 ML)
• Injection: 300/600 mg. ( VIAL WITH WFI)